These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12475232)

  • 21. Thermodynamic studies of a series of homologous HIV-1 TAR RNA ligands reveal that loose binders are stronger Tat competitors than tight ones.
    Pascale L; Azoulay S; Di Giorgio A; Zenacker L; Gaysinski M; Clayette P; Patino N
    Nucleic Acids Res; 2013 Jun; 41(11):5851-63. PubMed ID: 23605042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitors of protein-RNA complexation that target the RNA: specific recognition of human immunodeficiency virus type 1 TAR RNA by small organic molecules.
    Mei HY; Cui M; Heldsinger A; Lemrow SM; Loo JA; Sannes-Lowery KA; Sharmeen L; Czarnik AW
    Biochemistry; 1998 Oct; 37(40):14204-12. PubMed ID: 9760258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neamine dimers targeting the HIV-1 TAR RNA.
    Riguet E; Désiré J; Boden O; Ludwig V; Göbel M; Bailly C; Décout JL
    Bioorg Med Chem Lett; 2005 Nov; 15(21):4651-5. PubMed ID: 16153833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Argininamide binding arrests global motions in HIV-1 TAR RNA: comparison with Mg2+-induced conformational stabilization.
    Pitt SW; Majumdar A; Serganov A; Patel DJ; Al-Hashimi HM
    J Mol Biol; 2004 Apr; 338(1):7-16. PubMed ID: 15050819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydrogen-bonding contacts in the major groove are required for human immunodeficiency virus type-1 tat protein recognition of TAR RNA.
    Hamy F; Asseline U; Grasby J; Iwai S; Pritchard C; Slim G; Butler PJ; Karn J; Gait MJ
    J Mol Biol; 1993 Mar; 230(1):111-23. PubMed ID: 8450529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Site-specific incorporation of nitroxide spin-labels into internal sites of the TAR RNA; structure-dependent dynamics of RNA by EPR spectroscopy.
    Edwards TE; Okonogi TM; Robinson BH; Sigurdsson ST
    J Am Chem Soc; 2001 Feb; 123(7):1527-8. PubMed ID: 11456739
    [No Abstract]   [Full Text] [Related]  

  • 27. Fluorescence correlation spectroscopy at single molecule level on the Tat-TAR complex and its inhibitors.
    Nandi CK; Parui PP; Brutschy B; Scheffer U; Göbel M
    Biopolymers; 2008 Jan; 89(1):17-25. PubMed ID: 17764074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recognition of HIV TAR RNA by triazole linked neomycin dimers.
    Kumar S; Arya DP
    Bioorg Med Chem Lett; 2011 Aug; 21(16):4788-92. PubMed ID: 21757341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A peptide nucleic acid-neamine conjugate that targets and cleaves HIV-1 TAR RNA inhibits viral replication.
    Riguet E; Tripathi S; Chaubey B; Désiré J; Pandey VN; Décout JL
    J Med Chem; 2004 Sep; 47(20):4806-9. PubMed ID: 15369382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Attenuating HIV Tat/TAR-mediated protein expression by exploring the side chain length of positively charged residues.
    Wu CH; Chen YP; Liu SL; Chien FC; Mou CY; Cheng RP
    Org Biomol Chem; 2015 Dec; 13(45):11096-104. PubMed ID: 26399751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Probing the proximity of the core domain of an HIV-1 Tat fragment in a Tat-TAR complex by affinity cleaving.
    Huq I; Rana TM
    Biochemistry; 1997 Oct; 36(41):12592-9. PubMed ID: 9376365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The structure of the human immunodeficiency virus type-1 TAR RNA reveals principles of RNA recognition by Tat protein.
    Aboul-ela F; Karn J; Varani G
    J Mol Biol; 1995 Oct; 253(2):313-32. PubMed ID: 7563092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of RNA structure in arginine recognition of TAR RNA.
    Puglisi JD; Chen L; Frankel AD; Williamson JR
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3680-4. PubMed ID: 7682716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oligonucleotide analogue interference with the HIV-1 Tat protein-TAR RNA interaction.
    Arzumanov A; Walsh AP; Liu X; Rajwanshi VK; Wengel J; Gait MJ
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):471-80. PubMed ID: 11563062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for a base triple in the free HIV-1 TAR RNA.
    Huthoff H; Girard F; Wijmenga SS; Berkhout B
    RNA; 2004 Mar; 10(3):412-23. PubMed ID: 14970387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deciphering structure-activity relationships in a series of Tat/TAR inhibitors.
    Pascale L; González AL; Di Giorgio A; Gaysinski M; Teixido Closa J; Tejedor RE; Azoulay S; Patino N
    J Biomol Struct Dyn; 2016 Nov; 34(11):2327-38. PubMed ID: 26524629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural investigation of a high-affinity MnII binding site in the hammerhead ribozyme by EPR spectroscopy and DFT calculations. Effects of neomycin B on metal-ion binding.
    Schiemann O; Fritscher J; Kisseleva N; Sigurdsson ST; Prisner TF
    Chembiochem; 2003 Oct; 4(10):1057-65. PubMed ID: 14523924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monitoring tat peptide binding to TAR RNA by solid-state 31P-19F REDOR NMR.
    Olsen GL; Edwards TE; Deka P; Varani G; Sigurdsson ST; Drobny GP
    Nucleic Acids Res; 2005; 33(11):3447-54. PubMed ID: 15961729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of human immunodeficiency virus type 1 Tat-derived peptides with TAR RNA.
    Long KS; Crothers DM
    Biochemistry; 1995 Jul; 34(27):8885-95. PubMed ID: 7612630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ligand-induced changes in 2-aminopurine fluorescence as a probe for small molecule binding to HIV-1 TAR RNA.
    Bradrick TD; Marino JP
    RNA; 2004 Sep; 10(9):1459-68. PubMed ID: 15273324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.